CRESCENT BIOPHARMA, INC.（CBIO）内部人交易：高管与董事近期交易
过去 18 个月，共有 22 位内部人为 CRESCENT BIOPHARMA, INC.（CBIO）报告了 70 笔 Form 4 交易（最近一笔 2026-09-18）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-18 | Brumm Joshua T | Chief Executive Officer | 卖出 | 1,610 | $28,819 |
| 2026-09-18 | Brumm Joshua T | Chief Executive Officer | 卖出 | 7,837 | $130,956 |
| 2026-09-18 | Scalzo Richard William | Chief Financial Officer | 卖出 | 568 | $10,167 |
| 2026-09-18 | McNeill Jonathan | President and COO | 卖出 | 731 | $13,085 |
| 2026-09-18 | Im Ellie Eunkyung | Chief Medical Officer | 卖出 | 623 | $11,152 |
| 2026-09-18 | Bispham Barbara Harlin | General Counsel and Corporate Secretary | 卖出 | 620 | $11,098 |
| 2026-09-18 | Pinkas Jan | Chief Scientific Officer | 卖出 | 658 | $11,778 |
| 2026-09-18 | McNeill Jonathan | President and COO | 卖出 | 3,839 | $64,150 |
| 2026-09-18 | Lynch Ryan | Treasurer, Senior Vice President of Finance and Chief Accounting Officer | 卖出 | 240 | $4,296 |
| 2026-07-20 | Kiselak Tomas | 董事 | 买入 | 853,450 | $12.4M |
| 2026-07-20 | Harwin Peter Evan | 董事 | 买入 | 853,450 | $12.4M |
| 2026-07-20 | Fairmount Healthcare Fund II L.P. | 董事 | 买入 | 853,450 | $12.4M |
| 2026-07-20 | Fairmount Funds Management LLC | 董事 | 买入 | 853,450 | $12.4M |
| 2026-06-23 | Pinkas Jan | Chief Scientific Officer | 卖出 | 1,288 | $23,171 |
| 2026-06-23 | Scalzo Richard William | Chief Financial Officer | 卖出 | 1,112 | $20,005 |
| 2026-06-23 | McNeill Jonathan | President and COO | 卖出 | 20,549 | $369,677 |
| 2026-06-23 | Im Ellie Eunkyung | Chief Medical Officer | 卖出 | 1,219 | $21,930 |
| 2026-06-23 | Bispham Barbara Harlin | General Counsel and Corporate Secretary | 卖出 | 1,218 | $21,912 |
| 2026-06-23 | Lynch Ryan | Treasurer, Senior Vice President of Finance and Chief Accounting Officer | 卖出 | 465 | $8,365 |
| 2026-06-23 | Brumm Joshua T | Chief Executive Officer | 卖出 | 42,305 | $761,067 |
| 2025-12-17 | Bispham Barbara Harlin | General Counsel and Corporate Secretary | 买入 | 12,422 | $0 |
| 2025-12-17 | Doughty Christopher Grant | Chief Business Officer | 买入 | 14,714 | $0 |
| 2025-12-17 | Doughty Christopher Grant | Chief Business Officer | 买入 | 8,000 | $0 |
| 2025-12-17 | Brumm Joshua T | Chief Executive Officer | 买入 | 45,117 | $0 |
| 2025-12-17 | Brumm Joshua T | Chief Executive Officer | 买入 | 10,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18